Palvella Therapeutics (PVLA) EBIT Margin Growth (3y) (2017 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -327,995.00 |
| Sep 30, 2023 | 36,646.00 |
| Jun 30, 2023 | 5,168.00 |
| Mar 31, 2023 | -77,211.00 |
| Sep 30, 2022 | -469,702.00 |
| Jun 30, 2022 | -12,617.00 |
| Mar 31, 2022 | 5,716.00 |
| Dec 31, 2021 | 188,647.00 |
| Sep 30, 2021 | -58,963.00 |
| Jun 30, 2021 | -64,070.00 |
| Mar 31, 2021 | 15,704.00 |
| Dec 31, 2020 | -69,696.00 |
| Sep 30, 2020 | -31,028.00 |
| Jun 30, 2020 | 38,446.00 |
| Mar 31, 2020 | 56,705.00 |
| Dec 31, 2019 | 19,139.00 |
| Sep 30, 2019 | 76,774.00 |
| Jun 30, 2019 | 31,082.00 |
| Mar 31, 2019 | 22,638.00 |
| Dec 31, 2018 | -271,408.00 |
| Sep 30, 2018 | 84,227.00 |
| Jun 30, 2018 | 218,647.00 |
| Mar 31, 2018 | 150,486.00 |
| Sep 30, 2017 | 970,079.00 |
| Jun 30, 2017 | -2,914.00 |